\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes HorizonEU L+F Digital EuropeThe Indicative Audit Programme (IAP) has been published by the Commission on 15 July. This document is designed as a guide for financial audits in EU grants.
It is based on the corporate EU Model Grant Agreement that is used for all EU Programmes for the 2021-2027 EU financial framework and describes the context, objectives and standard procedures to ensure the conformity of project expenditure.
Together with the EU Grants AGA — Annotated Grant Agreement, it helps to explain the cost eligibility rules and the standards applied.
It is primarily designed for EU auditors, but can also be used as reference tool for other EU services, beneficiaries, etc.
Be aware: this is just a guide. It aims to define general principles and standards. The actual audits will be based on audit checklists and sampling methods that will be adapted to each programme and audit, and that may differ depending on factors such as type of funding programme, type of stakeholders, complexity, type of grant, type of action, specific risk factors, etc.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation Hubs
A new wave of calls under the Digital Europe programme is now open for submission. The Commission seeks project proposals for the following topics: AI Continent calls Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data tools Health: Data ingestion capacities a... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
